: Comparison of ChIP-seq Pipelines. (A) ChIPComp data was plotted from the CountSet object; results show a high number of false positive upregulated sites. (B) EdgeR normalisation is designed for the analysis of transcriptional data. In the case of large-scale unidirectional changes in binding, the assumption of normalisation fails giving rise to a distribution that is artificially symmetric.(C) DeSEQ2 makes use of similar assumptions and results in a similar distortion of data. (D) DiffBind utilises normalisation to total library size, and performs significantly better than the other three methods but does not attempt to control for systematic bias in pull-down efficiency of the ChIP. Reads corrected to total aligned reads showed the same off-centre peak density as observed with all that was not-normalised with an internal spike-in control. (B) Overlaying the MA plot combining the changes in chromatin binding of ER (black) and CTCF (grey). CTCF peaks overlay the off-centre peak density. (C) Utilising the CTCF binding events as a ground truth for 0-fold change, a linear fit to the log-fold change is generated (blue line). The fit is then also applied to the ER binding events. Figure S8 : Clustering of samples before and after ER and CTCF peak extractions shows the effect of fulvestrant on ER peaks drive clustering of the raw data. To confirm that the effects seen in Figure 2 were consistent across the genome, we compared the clustering of the CTCF and the ER peaks with respect to the treatment with fulvestrant. Initial clustering was weakly correlated with that of the treatment condition ( Figure S8A ). Clustering specifically to CTCF derived peak data ( Figure S8B ) resulted in a loss of grouping by treatment, while clustering specifically ER-derived peak data ( Figure S8C ) led to a clearer separation by treatment. Figure S10A . (B) Correction using the CTCF peaks to provide an internal control allows for the data to be corrected. Figure S12 : Comparison of DiffBind output before and after applying the corrected size factors from our pipeline generated from Drosophila spike-in control. (A) Analysis of ER binding before and after treatment with fulvestrant demonstrates that DiffBinds default normalisation strategy is more effective than the DESeq2 default (Fig S10A) , but demonstrates a bias between samples. (B) Applying the correct size factors from our DESeq2 pipeline reduces the bias in the analysis. Correlation heatmap generated from CTCF binding patterns shows that all samples except PDX02 are highly correlated. Darker green represents greater correlation, therefore this visulisation provides a QC step, identifying the ChIP of PDX02 has failed. (B) Heatmap generated from the correlation of ER binding patterns shows a much greater distance between PDX samples compared to CTCF, implying that different tumour models have ER binding distributed differently around the genome. PDX01 and PDX04 cluster most closely; a potential reason is PDX01 and PDX04 both express PR while PDX05 is classified as PR negative. The status of PDX03 is unknown.(C) Counts in peaks near three key loci normalise differently depending if RPM or parallel-factor ChIP (pfChIP-seq) is used. (D) CTCF control peaks show a reduced variability at each locus after normalisation with parallel-factor ChIP. RPM has minimal effect, demonstrating that parallel-ChIP is more able to control for sample variability. Figure S18 : Genome wide profile of parallel-factor ChIP-seq applied to PDX material. Analysis of CTCF binding of the raw data (top left) shows considerable variation between samples. Data was normalised to the CTCF binding events (top right). Raw ER binding profiles (bottom left) displays different levels in the global binding between each sample; however, no ground truth is known. After normalisation to CTCF PDX01, PDX03 and PDX04 all show similar levels of binding. PDX05 shows reduced genome-wide binding, consistent with being the only PDX to be derived from a tumour with an Allred score of 5 compared to all other samples (Allred = 8 ). 
